Memorial Hospital Research Laboratories
The Jason Lewis Lab
Research
The Lewis lab research interests are focused on the development of radiopharmaceuticals for targeted diagnosis and treatment of cancer. By combining small- and biomolecule-based targeting agents with positron-emitting or therapeutic radioisotopes, we can interrogate molecular profiles of cancer using noninvasive nuclear imaging or treat tumors specifically with endoradiotherapy. Our research program is a molecular-imaging-based program focused on the targeting of nonstandard nuclides, with an emphasis on developing these novel radiopharmaceuticals for clinical translation. A few examples of our work are given below.
Featured News
Publications
People
Jason S. Lewis, PhD
Emily Tow Jackson Chair in Oncology
- Radiochemist Jason Lewis develops molecular imaging agents for the imaging and therapy of cancer.
- PhD, The University of Kent (UK)
- lewisj2@mskcc.org
- Email Address
- 646-888-3038
- Office Phone
- View physician profile
- Physician profile
Members
- University of Maryland, Baltimore County (UMBC)
- BS in Chemistry
- MD
- 770-861-3438
- Office Phone
- BS in chemistry
- MD
Lab Alumni
Lab Affiliations
Achievements
- Distinguished Investigator Award, Academy Radiology Research (2014)
- Fellow, World Molecular Imaging Society (FWMIS) (2015)
- Michael J. Welch Award, SNMMI (2017)
- Fellow, Society of Nuclear Medicine and Molecular Imaging (FSNMMI) (2019)
- Paul C. Aebersold Award, ERF-SNMMI (2019)
Read more
- NCI R35 Outstanding Investigator Award (2019-2026)
- 2020 American Chemical Society Bioconjugate Chemistry Lecture Award
- 2021 Gold Medal for Lifetime Achievement, World Molecular Imaging Society
Lab News & Events
Get in Touch
-
Lab Head Email
-
Office Phone
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Jason S. Lewis discloses the following relationships and financial interests:
-
CSRA Inc.
Provision of Services -
CheMatech
Intellectual Property Rights -
Clarity Pharmaceuticals
Ownership / Equity Interests; Provision of Services -
Curie Therapeutics, Inc.
Provision of Services -
Daiichi Sankyo
Intellectual Property Rights -
Diaprost AB
Intellectual Property Rights -
Earli Inc.
Provision of Services -
Elsevier
Provision of Services -
Elucida Oncology
Intellectual Property Rights -
Evergreen Theragnostics
Ownership / Equity Interests; Provision of Services (uncompensated) -
Journal of Nuclear Medicine
Provision of Services
-
Longitude Capital Management Co., LLC
Provision of Services -
Samus Therapeutics LLC
Intellectual Property Rights -
Sharp RTx, Inc.
Intellectual Property Rights; Ownership / Equity Interests; Provision of Services (uncompensated) -
Summit Biomedical Imaging, LLC
Ownership / Equity Interests -
TPG Capital
Provision of Services -
Telix Pharmaceuticals Limited
Ownership / Equity Interests; Provision of Services (uncompensated) -
Theragnostics, Ltd.
Intellectual Property Rights -
Trace-Ability, Inc.
Ownership / Equity Interests; Provision of Services (uncompensated) -
World Molecular Imaging Society
Provision of Services -
pHLIP, Inc.
Intellectual Property Rights; Ownership / Equity Interests; Provision of Services
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.